Summary. Epidemiologic data suggest that having a parent with Type 2 (non-insulin-dependent) diabetes mellitus increases the risk for Type i (insulin-dependent) diabetes in siblings of a Type 1 diabetes proband. This increase in risk is consistent with a shared genetic susceptibility between Type i diabetes and Type 2 diabetes. We contrast genetic risk factors in three sets of families, consisting of (1) a single Type i diabetic child (proband) and non-diabetic parents, (2) multiple Type 1 diabetic siblings and non-diabetic parents, and (3) at least one Type 1 diabetic child and at least one Type 2 diabetic parent. Previous studies have demonstrated that HLA region genes, which elevate the risk in Type 1 diabetes, have no significant effect with respect to the risk for developing Type 2 diabetes. An earlier report cited a contribution by the haptoglobin locus to genetic susceptibility for Type 2 diabetes. We provide evidence that a high risk HLA antigen (HLA-DR3) is decreased to a greater extent in Type l patients with a Type 2 parent than in Type 1 patients in which the parents are not diabetic. The role of HLA-DR4 is maintained in these families, with an unexpectedly significant increased rate of transmission of the HLA-DR4 allele from Type 2 parent to Type 1 offspring. The role of haptoglobin in these families does not appear to be important, either with respect to association with diabetes or with respect to linkage with a secondary susceptibility locus. These results indicate that families with a Type 2 parent and Type 1 child, heavily determined by HLA-DR4 linked factors, may represent a homogeneous subset of diabetes susceptibility.
Insight into the pathogenesis of both Type 1 (insulin-dependent) diabetes mellitus and Type 2 (non-insulin-dependent) diabetes is compromised by their unresolved modes of inheritance. The most powerful predictor of risk for developing either Type 1 or Type 2 diabetes is being an identical (monozygotic, or MZ) twin of a diabetic. The MZ twin concordance for Type 1 diabetes is significantly less than 100%, ranging from 25%-50% [1, 2] . This decreased MZ twin concordance rate would imply that nonfamilial environmental factors play an important role in defining an individual's susceptibility to Type 1 diabetes. The "random" environmental factors themselves may be heterogeneous (prenatal, perinatal, cultural) , and further obscure the mode of genetic transmission. Heterogeneous environmental factors (environmental "triggers", such as viruses or exposures to pathogens) could effectively mask single gene effects. On the other hand, the MZ twin concordance rate for Type 2 diabetes is close to 100% [3] , indicating that the susceptibility is highly familial, with Type 2 diabetes determined by genetic and/or common environmental factors.
Although individual estimates of risk to relatives for Type 1 and Type 2 diabetes are variable, depending upon ethnic origin and clinical manifestation of disease, there is a clear relationship between the magnitude of diabetic risk with the degree of genetic relationship of the proband [4, 5] . As the degree of relationship decreases from MZ twin (100% of genes shared identical by descent), to firstdegree relatives (full siblings, parents and offspring; 50% shared), to second degree (25% shared) and third degree (12.5% shared) relatives, the risks for Type 1 and Type 2 diabetes decrease in a non-linear fashion. Under the assumption of no dominance, supported by equivalent risks to siblings and parents, single locus models predict a linear relationship between diabetic risk and the percent of genes shared identical by descent. The single locus models fail to account for the non-linear nature of familial risk for Type 1 and Type 2 diabetes [6] [7] [8] [9] . The degree of reduced penetrance required for a single locus to account for risks in distant relatives is difficult to reconcile with the observed MZ twin concordance rates for both Type i and Type 2 diabetes. The implication from these data is that additional loci contributing to the genetic susceptibility for both Type 1 and Type 2 diabetes are required.
In this report, we focus on the susceptibility to Type 1 diabetes in families distinguished by disease status of the parents of a Type 1 diabetic offspring. In one set of families, parents of the Type 1 proband are disease-free. In another set of families, at least one parent of the Type 1 proband has Type 2 diabetes. Family-type specific differences in relative risk or linkage relationships would represent evidence that locus-specific differences exist which relate to the Type 2 diabetes susceptibility in parents. We present evidence that HLA-DR4 or a factor in linkage disequilibrium or restricted by HLA-DR4 may contribute to the increased susceptibility of Type 1 diabetes in families with Type 2 diabetic parents.
Subjects and methods

Subjects
The families studied in this report consist of three types, distinguished by disease status in the parents (Type 2 diabetic or non-diabetic) and by the number of offspring with Type 1 diabetes (one, or more than one). Families designated as "pure Type 1 diabetes" have at least one offspring with Type i diabetes and both parents phenotypically normal. Within this group, those families with one Type 1 diabetic offspring (the proband) are termed "simplex", while those with the proband and at least one Type 1 diabetic sibling are termed "multisib". The "Type lfI'ype 2" families have at least one offspring with Type 1 diabetes and at least one parent with Type 2 diabetes.
All definitions of the diabetic state are made according to the criteria of the National Diabetes Data Group [10] . From our database of Type 1 families with HLA arid haptoglobin typing data, we ascertained 98 simplex families (normal parents and one Type 1 diabetic offspring), 36 multisib families (normal parents and two or more Type 1 offspring), and 28 Type 1/Type 2 families (at least one Type 2 parent and one or more Type 1 offspring).
This study was approved by the University of Minnesota Committee on the Use of Human Subjects in Research, and each individual signed a consent form upon admission to the University of Minnesota General Clinical Research Center.
Experimental measurements
Typing for HLA and haptoglobin were performed in an unbiased, blinded protocol without regard to presence of Type 2 diabetes in parents or by number of Type 1 diabetes in offspring. In the 28 Type 1/Type 2 families, HLA-A and HLA-B typing data were available for 24 and HLA-DR typing data were available for 18 families. HLA data were available for all 98 Type 1 simplex families and 36 Type i multisib families. Control data for HLA antigens were provided from the population of donors (617 for HLA-A, HLA-B and 511 for HLA-DR) at the University of Minnesota Hospitals for the Eighth International Workshop as previously reported [11] . Control data for haptoglobin typing were provided from 168 unrelated nondiabetic individuals [12] .
HLA-A, HLA-B, and HLA-DR antigens were determined on all available family members. All HLA typing was performed in the HLA laboratories of the University of Minnesota Hospitals and Clinics by published methods [13] . Haptoglobin typing was performed using plasma in a modification of the method of Roy [14] . This modification preferentially keeps haptoglobin soluble while precipitating other plasma proteins. Purified 1-1 haptoglobin (Biomedical Frontiers, Minneapolis, Minn., USA) and 2-1 haptoglobin (Alpha Therapeutics Corporation, Chicago, Ill., USA) samples were prepared and 351 run as standards on sodium dodecyl sulphate-polyacrylamide gels [15] . Both samples and molecular weight markers (BioRad Laboratories, Richmond, Calif., USA) were loaded and electrophoresed at a constant amperage until 5 rain after the tracking dye exited the gels. Gels were processed by fixing in 50% methanol and 10% acetic acid for 1 h, staining in 0.05% Coomassie Brilliant Blue G-250 (Serva, Paramus, N J, USA) in 5% perchloric acid for 20 min, and destaining in two changes of 7% acetic acid and 5% methanol. All gels were dried under vacuum, photographed, and evaluated for haptoglobin Hp 1-1, Hp 2-1, and Hp 2-2 genotypes.
Statistical analysis
Statistical analyses were performed using chi-square tests of association. Since specific HLA antigens have been implicated in the pathogenesis of Type 1 diabetes, only the three HLA-B and two HLA-DR antigens were tested so that no correction for multiple antigen comparisons is required. Sib-pair analyses were used as a procedure to screen for linkage of HLA and haptoglobin with Type 1 diabetes in all families [16, 17] . The sib-pair analysis reduces to a twosample t-test between trait-concordant and trait-discordant sibships, with respect to the mean proportion of genes identical by descent (IBD)at the marker [18] . The dependent variable is the probability that a sibling pair is discordant for diabetic susceptibility, which is a function of the age of each individual (sibling) and the mean and variance of the age of onset distribution. The regression coefficient for the probability that a sib-pair is discordant on the proportion of genes IBD at a marker is then estimated and tested for significance by a standard t-test. The average proportion of marker genes IBD for trait concordant sib-pairs (diabetic/diabetic and nondiabetic/non-diabetic) should be greater than half (the expected value under the assumption of no linkage). Similarly, the average proportion of marker genes IBD for trait discordant sib-pairs (diabetic/non-diabetic) should be less than half.
Results
The age at onset and sex distributions of Type 1 diabetes probands in Type 1 diabetes simplex and Type 1 diabetes multisib families are similar to that observed in other studies of Type 1 diabetes. The sex distribution of Type 1 diabetes probands in the Type1 diabetes simplex (46 males : 52 females) and Type 1 diabetes multisib (22 males :14 females) families does not differ greatly from the expected 1:1 ratio. However, the sex ratio of Type 1 diabetes probands in the Type 1/Type 2 families (9 males: i9 females) differed significantly (p < 0.05) from that observed in most Type 1 diabetes proband studies. Further, the age at onset distribution of the Type 1 diabetes probands in the Type 1/Type 2 diabetes families (18.3 + 2.0 years) is significantly (p < 0.05) older than in either the Type i diabetes simplex (11.5 + 0.8 years) or the Type 1 diabetes multisib (11.6 + 1.1 years) families. The difference in age at onset and sex distribution of the Type i diabetes probands in Type 1/Type2 diabetes families may be due either to genetic heterogeneity or chance (small numbers).
Association
Distributions of tested HLA antigen frequencies in Type 1 probands and local control subjects and estimates of relative risks for Type 1 diabetes are given in Table 1 .
In the Type 1 simplex probands, there are statistically significant (p <0.05) elevated relative risks (RR) for HLA-B8 (RR = 2.31), HLA-B15 (RR = 2.41), HLA-B40 (RR=2.10), HLA-DR3 (RR=3.21) and HLA-DR4 (RR--5.09). These results are in agreement with previous studies and are partially the result of linkage disequilibrium which exists between HLA-B and HLA-DR alleles (BS-DR3, B15-DR4, and B40-DR4). In the Type 1 multisib probands, statistically significant elevated relative risks were also seen for HLA-B8 (RR = 2.69), HLA-B15 (RR=3.65), HLA-DR3 (RR=2.74) and HLA-DR4 (RR = 3.09). These HLA antigens, with the exception of HLA-B40, are the same and of the same magnitude of risk as those increased in the Type 1 simplex probands. The similarity in high risk antigens and magnitude of risk may indicate relative homogeneity in genetic susceptibility between Type i simplex and Type 1 multisib probands. In Type 1/Type 2 probands, significantly elevated relative risks are found for HLA-B15 (RR=2.37), HLA-B44 (RR=2.10), and HLA-DR4 (RR = 4.32). In this subset of Type 1 diabetic patientsthose with at least one parent with Type 2 diabetesthere is an absence of susceptibility due to the HLA B8-DR3 haplotype. Only DR4-linked haplotypes, B15-DR4 and B44-DR4, appear to be associated with increased risk for Type 1 diabetes in families with at least one Type 2 diabetes parent.
Distributions of haptoglobin genotypes in Type 1 probands and local control subjects are given in Table 2 . In these patients, there is no significant association between a specific haptoglobin genotype and Type 1 diabetes. There is an excess of the haptoglobin Hp-1 allele in the patients from the Type i simplex families, but the distribution of haptoglobin genotypes does not differ significantly from that of our local control subjects (Z22 = 4.05,p = 0.13). These data indicate that there is little evidence suggesting that a specific haptoglobin genotype or allele is associated with Type i diabetes. 
HLA-DR4 transmission
One measure of the importance of HLA-DR4 in families with a Type 1 diabetes proband and at least one Type 2 diabetes parent is the frequency of transmission of HLA-DR4 from Type 2 parent to Type i child. If HLA-DR4 is contributing to Type 1 diabetes greater in degree than expected, then HLA-DR4-positive Type i diabetic patients would be expected to have received the HLA-DR4 from their Type 2 diabetic parent more often than expected based upon Mendelian segregation. In the families with a Type i diabetes proband and at least one Type 2 diabetes parent which were typed for HLA-DR, a total of 11 families had both parents HLA-typed and had a Type 1 diabetic subject who was HLA-DR4-positive. In these 11 Type 1 diabetic subjects, the HLA-DR4 allele was con-tributed by the Type 2 diabetic parent in 9 cases (82%), significantly (p < 0.05) higher than expected under Mendelian segregation (50%).
Discussion
A common theme in diabetes research has been that Type 1 diabetes is aetiologically distinct from Type 2 diabetes. Type i diabetes is considered to be autoimmune and is clearly associated with specific HLA antigens and demonstrates linkage of a major susceptibility locus with the HLA complex [19] [20] [21] [22] . Type 2 diabetes is thought not to be autoimmune and has not shown a consistent association or linkage with genes in the HLA region. On the other hand, there is an increased risk for Type 1 diabetes in siblings when a Type 1 diabetic proband has a Type 2 diabetic parent [4, 5] . We present evidence here that the genetic relationship between Type I and Type 2 diabetes may be accounted for, in part, through the HLA-DR4 antigen.
A popular hypothesis is that separate major genes are responsible for Type 1 and Type 2 susceptibility. These major locus models are attractive for several reasons, the primary one being that a major locus has a high probability of being mapped to a chromosomal location. Although genetic susceptibility to Type i diabetes is strongly influenced by genes in the HLA region of human chromosome 6, not all of the susceptibility is accounted by this one region. This can be seen by the observation that 55% of trait concordant sibling pairs (both siblings have Type 1 diabetes), will have the same HLA region genes (haplotypes), 40% of the sibling pairs will have only one haplotype in common, while 5% of the sibling pairs will have no HLA haplotypes in common [23] . Although a multifactorial source of genetic liability to Type 1 diabetes and/or Type 2 diabetes is a concern for gene mapping, there is no need to imply that multifactorial inheritance implies hundreds of loci. Rather, there remains the more likely outcome that Type 1 and Type 2 diabetes are each the result of the actions of a limited number of genes (a major gene and some genes with small effect). Thus, of the additional loci required for at least some forms of Type 1 diabetes and Type 2 diabetes, some overlap may occur.
Several studies have documented the increased Type 1 diabetes risk to siblings of a Type i diabetic proband when a parent has Type 2 diabetes [4, 5] . This increase in risk is similar in magnitude to that seen for siblings of a Type 1 diabetes proband when a parent has Type 1 diabetes. With multiple loci required for both Type 1 diabetes and Type 2 diabetes, the possibility exists that a single locus may contribute to the susceptibility to both diseases. A genetic relationship between susceptibility for Type 1 diabetes and Type 2 diabetes would allow for a resolution between the models which have been proposed to explain the observed clinical heterogeneity and expression of both Type 1 diabetes and Type 2 diabetes. Recent studies [24] have demonstrated an increased serum viscosity in Type 2 diabetes patients with microvascular disease which has been linked to changes in serum protein composition. The major change observed is a decline in albumin and an in-353 crease in the levels of acute-phase proteins (including haptoglobin). Acute-phase proteins also were increased in advanced glucose intolerance as well as in established Type 2 diabetes, although there was no relationship with degree of control or duration of diabetes. Although this effect may be due to metabolic changes (increased blood glucose), the examination of families with both Type 2 and Type 1 diabetes with respect to genetic markers could be highly informative in defining mutual risk factors.
HLA antigen distributions in the Micronesian population of Nauru [25] showed a small increased risk for early onset of diabetes (less than 46 years) associated with HLA-Bw22 (Bw56). In a series of studies [26, 27] , islet cell antibodies (ICAs), thyrogastric antibodies, and HLA-DR antigens were determined in 204 patients with Type 2 diabetes controlled with diet and/or oral hypoglycaemic agents and in 108 age-matched patients who required insulin to control their hyperglycaemia. The insulin-requiring patients differed from the non-insulin-requiring patients with respect to higher frequency of ICAs, thyroid antibodies, and HLA-DR4 frequency. Patients who were heterozygous for HLA-DR3/DR4 showed significantly higher frequency of ICAs and complement-fixing ICAs than patients without the heterozygous form DR3/DR4. These data suggested that Type 2 diabetes is a heterogeneous disorder including at least two major subgroups, characterized by HLA-DR antigens and organ-specific antibodies.
The role of genetic markers other than HLA in contributing to susceptibility to both Type i diabetes and Type 2 diabetes has been equivocal. In a Mexican American population randomly selected from three San Antonio neighbourhoods, statistically significant associations were found between Type 2 diabetes and the Rhesus blood type and haptoglobin phenotype [28, 29] . The haptoglobin association showed a dose effect with a single dose of the Hp-1 allele associated with a 50% increased Type2 diabetes prevalence and a HP 1-1 homozygote was associated with a 100% increase in Type 2 diabetes prevalence. In a separate study of association between Type 2 diabetes and seven polymorphic markers using 398 Caucasian subjects (97 Type 2 diabetes and 301 normal individuals) and 390 Hispanic subjects (191 Type 2 diabetes and 199 normal individuals), there was no association with either haptoglobin or Rh [30] . In our families with at least one Type 2 diabetic parent and a Type 1 diabetic child, the haptoglobin genotype does not appear to be a significant contributor to diabetes susceptibility, either with respect to association with diabetes or with respect to linkage with a secondary susceptibility locus.
Haptoglobin phenotyping in patients at risk for myocardial infarction and essential hypertension have previously demonstrated a significant increase in the incidence of the Hp 2-2 phenotype in the high-risk group, as compared to a group of normal subjects [31, 32] . Since there is a significant risk of cardiovascular events in patients with Type 2 diabetes [33] , existence of a mechanism involving haptoglobin (either plasma levels or genotypes) in the pathogenesis of cardiovascular disease may be sufficient to appear important in subsets of Type 2 diabetes patients.
The possible relationship between haptoglobin phenotype and Type i diabetes, insulin antibodies and microangiopathy has been previously studied [34] . There were no differences regarding the distribution of haptoglobin phenotypes in patients in comparison with control subjects. There also were no relationships between haptoglobin genotype and diabetic microangiopathy (retinopathy, nephropathy) or insulin antibody binding. However, both the maximum insulin binding capacity and the equilibrium dissociation constant were found to vary considerably with the haptoglobin genotype among Type 1 diabetic patients. Differences between insulin binding parameters, reflecting differences in haptoglobin genotype, may be of clinical importance.
In summary, we present data which is consistent with Type 1 and Type 2 diabetes sharing factor(s) responsible for genetic susceptibility in at least some families. The data supportive of this contention include the previously reported significantly increased cumulative risk for Type 1 diabetes in siblings of Type 1 probands with a Type 2 diabetic parent and the increased relative risk for Type 1 diabetes associated with HLA-DR4 but not HLA-DR3 in these families. These results provide evidence that families with a Type 2 parent and Type 1 child, heavily determined by HLA-DR4 linked factors, may represent a homogeneous subset of diabetes susceptibility.
